Zdrowie i gospodarka · 19/07/2000

FDA Publishes Draft Revised Guidance on Impurities in New Drug Products

The Food and Drug Administration (FDA) has released a draft revised guidance on impurities in new drug products, which updates a 1997 guidance and aligns with more recent International Conference on Harmonisation (ICH) guidelines, to help with the registration or marketing of new drug substances.